IRONWOOD PHARMACEUTICALS INC (IRWD)
US46333X1081 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -1.03B | 175.06M | 528.45M | 106.20M | 21.50M | |||
| Depreciation Amortization | 1.57M | 1.42M | 1.52M | 3.60M | 5.60M | |||
| Income Taxes - Deferred | 72.64M | 65.74M | -333.29M | N/A | N/A | |||
| Change In Working Capital | 11.28M | 2.82M | 17.73M | -900.00K | -100.00M | |||
| Interest Paid | 13.55M | 5.75M | 7.22M | 7.20M | 17.60M | |||
| Taxes Paid | 9.95M | 4.62M | 3.45M | 1.80M | N/A | |||
| Other non cash items | 1.13B | 28.72M | 47.49M | 60.00M | 83.60M | |||
| OPERATING CASH FLOW | 183.43M | 273.76M | 261.89M | 168.80M | 10.70M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -1.03B | -136.00K | -265.00K | -1.80M | -7.20M | |||
| Other Investing Activity | N/A | N/A | 0.00 | N/A | -4.00M | |||
| INVESTING CASH FLOW | -1.03B | -136.00K | -265.00K | -1.80M | -11.10M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 300.00M | -120.70M | 0.00 | 0.00 | 16.30M | |||
| Stock Issued/Repurchased | 6.36M | -116.85M | -4.55M | 18.50M | -8.40M | |||
| Other Financing Activity | -29.20M | N/A | 0.00 | N/A | -9.00M | |||
| FINANCING CASH FLOW | 277.16M | -237.55M | -4.55M | 18.50M | -1.20M | |||
| Exchange Rate Effect | -53.00K | N/A | N/A | N/A | N/A | |||
| CHANGE IN CASH | -565.78M | 36.07M | 257.08M | 185.50M | -1.60M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 183.43M | 273.76M | 261.89M | 168.80M | 10.70M | |||
| Capital Expenditure | -1.03B | -136.00K | -265.00K | -1.80M | -7.20M | |||
| FREE CASH FLOW | -842.89M | 273.63M | 261.63M | 167.00M | 3.50M | |||
All data in USD